10.1002/ejoc.201900246
European Journal of Organic Chemistry
FULL PAPER
(d, J = 0.8 Hz, 3H), 1.32 (s, 12H) ppm. 13C NMR (75 MHz, CDCl3): δ =
159.58, 157.80, 145.55, 129.19, 118.55, 113.76, 111.53, 83.11, 55.37,
25.04, 20.33 ppm. HRMS (ESI, micro TOF) m/z: calcd for C16H23BNaO3
[M+Na]+ 297.1635, found 297.1635.
(E)-4,4,5,5-Tetramethyl-2-{2-[2-(trifluoromethyl)phenyl]prop-1-en-1-
yl}-1,3,2-dioxaborolane (2n). Rf = 0.5 (cyclohexane/diethyl ether, 12:1).
1H NMR (400 MHz, CDCl3): δ = 7.61 (d, J = 7.9 Hz, 1H), 7.46 (t, J = 7.6,
0.6 Hz, 1H), 7.33 (t, J = 7.7 Hz, 1H), 7.20 (d, J = 7.7 Hz, 1H), 5.25 (d, J =
0.7 Hz, 1H), 2.30 (d, J = 0.7 Hz, 3H), 1.31 (s, 12H) ppm. 13C NMR (100
MHz, CDCl3): δ = 158.33, 146.17, 131.48, 129.11, 127.04, 126.89 (q, J =
30.2 Hz), 126.09 (q, J= 5.2 Hz), 124.40 (q, J = 273.7 Hz), 83.16, 25.04,
23.74 (q, J = 1.9 Hz) ppm. HRMS (ESI, micrOTOF) m/z: calcd for
C16H20BF3NaO2 [M+Na]+ 335.1404, found 335.1389.
(E)-2-[2-(2-Methoxyphenyl)prop-1-en-1-yl)]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (2f): Rf = 0.4 (cyclohexane/diethyl ether, 10:1). 1H NMR
(400 MHz, CDCl3): δ = 7.29 – 7.20 (m, 1H), 7.18 (dd, J = 7.4, 1.9 Hz, 1H),
6.97– 6.86 (m, 1H), 5.41 (q, J = 1.0 Hz, 1H), 3.80 (s, 3H), 2.34 (d, J = 1.0
Hz, 3H), 1.30 (s, 12H) ppm. The NMR data are in agreement with the
literature.21
2o and 3o have been isolated as a mixture:
(E)-2-[2-(4-Chlorophenyl)prop-1-en-1-yl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (2g): Rf = 0.45 (cyclohexane/diethyl ether, 12:1). 1H NMR
(400 MHz, CDCl3): δ = 7.42 (d, J = 8.8 Hz, 2H), 7.28 (d, J = 8.8 Hz, 2H),
(E)-2-[3-(Benzyloxy)-2-methylprop-1-en-1-yl]-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (2o) (major isomer): Rf = 0.3 (cyclohexane/diethyl
ether, 10:1). 1H NMR (400 MHz, CDCl3): δ = 7.39–7.24 (m, 5H), 5.50 (d, J
= 0.5 Hz, 1H), 4.51 (s, 2H), 3.97 (d, J = 0.8 Hz, 2H), 2.00 (s, 3H), 1.29 (s,
12H) ppm. 13C NMR (100 MHz, CDCl3): δ = 157.61, 138.52, 128.42,
127.67, 127.58, 82.92, 76.18, 72.18, 24.98, 18.21 ppm. HRMS (ESI,
micrOTOF) m/z: calcd for C17H25BKO3 [M+K]+ 327.1531, found 327.1538.
5.73 (d, J = 0.9 Hz, 1H), 2.38 (d, J = 0.9 Hz, 3H), 1.31 (s, 12H) ppm. 13
C
NMR (100 MHz, CDCl3): δ = 156.45, 142.34, 133.91, 128.42, 127.27,
83.21, 25.03, 20.13 ppm. HRMS (ESI, micrOTOF) m/z: calcd for
C15H20BClNaO2 [M+Na]+ 301.1140, found 301.1149.
(E)-2-[2-(3-Chlorophenyl)prop-1-en-1-yl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (2h): Rf = 0.45 (cyclohexane/diethyl ether, 12:1). 1H NMR
(300 MHz, CDCl3): δ = 7.50–7.43 (m, 1H), 7.39–7.33 (m, 1H), 7.26–7.22
(m, 2H), 5.75 (d, J = 0.8 Hz, 1H), 2.38 (d, J = 0.8 Hz, 3H), 1.31 (s, 12H)
ppm. The NMR data are in agreement with the literature.21
(E)-2-[1-(Benzyloxy)but-2-en-2-yl]-4,4,5,5-tetramethyl-1,3,2-dioxabo-
rolane (3o) (minor isomer): Rf = 0.3 (cyclohexane/diethyl ether, 10:1). 1H
NMR (400 MHz, CDCl3): δ = 7.39–7.24 (m, 5H), 6.41 (q, J = 6.7 Hz, 1H),
4.52 (s, 2H), 4.08 (s, 2H), 1.97 (dt, J = 6.9, 1.3 Hz, 3H), 1.29 (s, 12H)
ppm. 13C NMR (100 MHz, CDCl3): δ = 143.54, 139.12, 128.28, 127.71,
127.33, 83.13, 74.31, 71.92, 24.98, 17.33 ppm. HRMS (ESI, micrOTOF)
m/z: calcd for C17H25BKO3 [M+K]+ 327.1531, found 327.1538.
(E)-2-[2-(2-Chlorophenyl)prop-1-en-1-yl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (2i): Rf = 0.45 [cyclohexane/diethyl ether (12:1)]. 1H NMR
(400 MHz, CDCl3): δ = 7.35–7.31 (m, 1H), 7.21–7.16 (m, 3H), 5.34 (q, J =
1.0 Hz, 1H), 2.33 (d, J = 1.1 Hz, 3H), 1.32 (s, 12H) ppm. 13C NMR (100
MHz, CDCl3): δ = 158.83, 145.70, 131.06, 129.68, 129.27, 128.24,
126.74, 83.18, 25.08, 22.23 ppm. HRMS (ESI, micrOTOF) m/z: calcd for
C15H20BClNaO2 [M+Na]+ 301.1140, found 301.1134.
Standard procedure for the intramolecular carboboration of alkynes
catalyzed by (α-ICyD)CuCl (Table 2).
An oven-dried screwed tube was charged with (α-ICyD)CuCl (0.008
mmol, 19.4 mg) or (IPr)CuCl (0.008 mmol, 3.9 mg) and
bis(pinacolato)diboron (0.20 mmol, 50.2 mg). After being sealed with a
septum, the tube was purged by 3 vacuum-argon cycles. THF (0.3 mL)
was added and the mixture was stirred for 5 min at 20 °C. A solution of
tBuOK 1.0 M in THF (0.2 mL) was added. After stirring for 30 min, the
alkyne (0.1 mmol) was added. The tube was sealed with a screw cap and
the mixture was stirred at 60 °C for 24-27 h. After cooling, the crude
reaction mixture was filtered through a short pad of celite by rinsing with
diethyl ether, and concentrated under vacuum. The crude residue was
purified by silica gel chromatography (cyclohexane/diethyl ether). The
conversion of the alkyne and NMR yield of the product were determined
by 1H NMR analysis of the crude reaction mixture by comparison with the
internal reference (1,3,5-trimethoxybenzene), and the regioselectivity of
the reaction was determined by 1H NMR of the crude reaction mixture.
(E)-2-[2-(4-Fluorophenyl)prop-1-en-1-yl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (2j): Rf = 0.45 (cyclohexane/diethyl ether, 12:1). 1H NMR
(400 MHz, CDCl3): δ = 7.50–7.43 (m, 2H), 7.03–6.96 (m, 2H), 5.70 (d, J =
0.7 Hz, 1H), 2.38 (d, J = 0.9 Hz, 3H), 1.31 (s, 12H) ppm. The NMR data
are in agreement with the literature.21
(E)-2-[2-(2-Fluorophenyl)prop-1-en-1-yl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (2k): Rf = 0.45 (cyclohexane/diethyl ether, 12:1). 1H NMR
(400 MHz, CDCl3): δ = 7.28 (td, J = 7.7, 1.8 Hz, 1H), 7.22 (dddd, J = 8.1,
6.9, 5.0, 1.8 Hz, 1H), 7.07 (td, J = 7.5, 1.2 Hz, 1H), 7.01 (ddd, J = 11.1,
8.2, 1.1 Hz, 1H), 5.55 (s, 1H), 2.38 (dd, J = 1.6, 1.1 Hz, 3H), 1.31 (s,
12H) ppm. The NMR data are in agreement with the literature.21
(E)-4,4,5,5-Tetramethyl-2-{2-[4-(trifluoromethyl)phenyl]prop-1-en-1-
yl}-1,3,2-dioxaborolane (2l): Rf = 0.5 (cyclohexane/diethyl ether, 12:1).
1H NMR (400 MHz, CDCl3): δ = 7.57 (s, 4H), 5.79 (d, J = 0.9 Hz, 1H),
2.41 (d, J = 0.9 Hz, 3H), 1.32 (s, 12H) ppm. The NMR data are in
agreement with the literature.23
2-(Cyclopentylidenemethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
(5a): Rf = 0.4 (cyclohexane/diethyl ether, 10:1). 1H NMR (400 MHz, C6D6)
δ = 5.68 (p, J = 2.1 Hz, 1H), 2.76 (t, J = 7.3 Hz, 2H), 2.26 (t, J = 7.3 Hz,
2H), 1.60–1.51 (m, 2H), 1.47–1.39 (m, 2H), 1.12 (s, 12H) ppm. The NMR
data are in agreement with the literature.24
(E)-4,4,5,5-Tetramethyl-2-{2-[3-(trifluoromethyl)phenyl]prop-1-en-1-
yl}-1,3,2-dioxaborolane (2m): Rf = 0.5 (cyclohexane/diethyl ether, 12:1).
1H NMR (400 MHz, CDCl3): δ = 7.73 (s, 1H), 7.65 (d, J = 7.8 Hz, 1H),
7.53 (d, J = 7.8 Hz, 1H), 7.43 (t, J = 7.8 Hz, 1H), 5.79 (d, J = 0.9 Hz, 1H),
2.41 (d, J = 0.9 Hz, 3H), 1.32 (s, 12H) ppm. 13C NMR (100 MHz, CDCl3):
δ = 156.18, 144.73, 130.73 (q, J = 32.1 Hz), 129.16 (d, J = 1.1 Hz),
128.77, 124.62 (q, J = 3.7 Hz), 124.33 (d, J = 272.3 Hz), 122.81 (q, J =
3.8 Hz), 83.32, 25.04, 20.12 ppm. HRMS (ESI, micrOTOF) m/z: calcd for
C16H20BF3NaO2 [M+Na]+ 335.1404, found 335.1406.
2-(Cyclohex-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (6a):
Rf = 0.4 (cyclohexane/diethyl ether, 10:1). 1H NMR (400 MHz, CDCl3): δ =
6.59–6.53 (m, 1H), 2.13–2.04 (m, 4H), 1.60–1.56 (m, 4H), 1.25 (s, 12H).
The NMR data are in agreement with the literature.25
(E)-2-[(Dihydrofuran-3(2H)-ylidene)methyl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (5b): Rf = 0.4 (cyclohexane/diethyl ether, 10:1). 1H NMR
(400 MHz, CDCl3): δ = 5.31–5.26 (m, 1H), 4.29 (d, J = 1.5 Hz, 2H), 3.93
(t, J = 7.0 Hz, 2H), 2.83–2.76 (m, 2H), 1.27 (s, 12H) ppm. 13C NMR (100
MHz, CDCl3): δ = 165.04, 83.10, 73.24, 69.30, 33.39, 25.03 ppm. HRMS
This article is protected by copyright. All rights reserved.